CCSP C2 Human Ovarian Cancer subpopulation cell line
Invented by Professor Karl Skorecki , Ehood Katz , Maty Tzukerman
Invented at Rambam Health Care Campus
- References (1)
- Inventor Info
|Disease Keywords||Ovarian Cancer|
The CCSP family of six cell lines aims to recapitulate the ovarian cancer microenvironment, and is suitable for investigation into cancer biology and cancer therapeutics research. These lines are derived from malignant ascites; a common destination for malignant ovarian cancer cells.
They have been validated in direct human-to-mouse xenografts (SCID/beige mouse muscle) and human embryonic stem cell models. The CCSP lines demonstrate morphological hallmarks of ovarian cancer and are positive for clinically relevant ovarian cancer biomarkers CA-125, CA-19.9, and MUC1, as well as the epithelial-specific antigen Ber-EP4. Tumourigenicity has been confirmed for all CCSP sub-populations in the human embryonic stem cell model, and specific sub-populations in the mouse xenograft model.
There are 1 reference entries for this reagent.View All References
Professor Karl Skorecki